US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NUTRIBAND INC C/WTS (TO PUR COM)

1.35

+0.05003.85%

Volume:1.12K

Turnover:1.72K

Market Cap:18.82M

PE:-0.44

High:1.40

Open:1.40

Low:1.35

Close:1.30

52wk High:4.50

52wk Low:0.8000

Shares:13.94M

Float Shares:13.94M

Volume Ratio:6.13

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0655

ROE:-136.08%

ROA:-55.22%

PB:2.49

PE(LYR):- -

Loading ...

Overview Company News Filings

BRIEF-Nutriband Signs Exclusive Distribution Agreement With Innomedica For Aversa Fentanyl

Nutriband Signs Exclusive Distribution Agreement With Innomedica for Aversa Fentanyl and All Sports Tape Products for Costa Rica

THOMSON REUTERS

Press Release: Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

Nutriband CEO Publishes Letter to Shareholders

Nutriband Inc - Proceeds to Fund Development of Aversa Fentanyl Patch

THOMSON REUTERS

Nutriband Inc - Shareholders to Retain 10% Stake in Earth Vision Bio

THOMSON REUTERS

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Nutriband Inc - Meets With FDA for Aversa Fentanyl Feedback

THOMSON REUTERS

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Press Release: Nutriband Co-Founder Gareth Sheridan Returns as CEO

Nutriband Inc - Files Provisional Patent Application With Uspto for Aversa Technology

THOMSON REUTERS

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference

Press Release: Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NTRBW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTRBW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTRBW\",,,,,undefined,":{"symbol":"NTRBW","market":"US","secType":"STK","nameCN":"NUTRIBAND INC C/WTS (TO PUR COM)","latestPrice":1.35,"timestamp":1771966800000,"preClose":1.3,"halted":0,"volume":1123,"delay":0,"changeRate":0.03846153846153849,"floatShares":13942714,"shares":13942714,"eps":-3.0655,"marketStatus":"Pre-Mkt","change":0.05,"latestTime":"02-25 08:26:20 EST","open":1.4,"high":1.4,"low":1.35,"amount":1716.6,"amplitude":0.038462,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.0655,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772029800000},"marketStatusCode":1,"adr":0,"listingDate":1633060800000,"exchange":"NASDAQ","adjPreClose":1.35,"volumeRatio":6.1299073101246195},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTRBW\",,,,,undefined,":{"symbol":"NTRBW","floatShares":13942714,"roa":"-55.22%","roe":"-136.08%","lyrEps":0,"volumeRatio":6.1299073101246195,"shares":13942714,"dividePrice":0,"high":1.4,"amplitude":0.038462,"preClose":1.3,"low":1.35,"week52Low":0.8,"pbRate":"2.49","psRate":"8.26","week52High":4.5,"institutionHeld":0,"latestPrice":1.35,"eps":-3.0655,"divideRate":0,"volume":1123,"delay":0,"ttmEps":-3.0655,"open":1.4,"prevYearClose":1.61,"prevWeekClose":1.3,"prevMonthClose":1.6,"prevQuarterClose":1.61,"fiveDayClose":1.3,"twentyDayClose":1.6,"sixtyDayClose":1.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTRBW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTRBW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTRBW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTRBW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612454178","title":"BRIEF-Nutriband Signs Exclusive Distribution Agreement With Innomedica For Aversa Fentanyl","url":"https://stock-news.laohu8.com/highlight/detail?id=2612454178","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612454178?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:39","pubTimestamp":1771331986,"startTime":"0","endTime":"0","summary":"BRIEF-Nutriband Signs Exclusive Distribution Agreement With Innomedica For Aversa Fentanyl Feb 17 (Reuters) - Nutriband Inc NTRB.O:NUTRIBAND SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT WITH INNOMEDICA FOR ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUA7J4BT7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTRBW","NTRB","BK4007"],"gpt_icon":0},{"id":"2612345188","title":"Nutriband Signs Exclusive Distribution Agreement With Innomedica for Aversa Fentanyl and All Sports Tape Products for Costa Rica","url":"https://stock-news.laohu8.com/highlight/detail?id=2612345188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612345188?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:00","pubTimestamp":1771329602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUA2DJ39B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTRBW","BK4007","NTRB"],"gpt_icon":0},{"id":"2607278017","title":"Press Release: Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points","url":"https://stock-news.laohu8.com/highlight/detail?id=2607278017","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607278017?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:00","pubTimestamp":1769774400,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Jan. 30, 2026  -- Nutriband Inc.   has provided an update to shareholders on the key milestones and discussions from this years Annual Shareholders Meeting, held on Jan 24, 2026 in Orlando, Florida. Details and highlights may be found below.Alessandro Puddu is an Italian Chartered Accountant and Statutory Auditor with over 10 years of experience in audit, corporate advisory and financial reporting for industrial groups and listed companies.He advises companies on tax and corporate matters, company valuations, extraordinary corporate transactions and IAS/IFRS reporting, including consolidated financial statements. He has supported the design and implementation of accounting and administrative procedures and regularly serves as statutory auditor and member of statutory boards of Italian companies.Alessandro Puddu is enrolled in the Italian Register of Chartered Accountants , the Register of Statutory Auditors held by the Italian Ministry of Economy and Finance, and the Reg","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","NTRBW","BK4099","BK4585","PCOM","LU0321505439.SGD","LU0321505868.SGD","HAL","LU0985481810.HKD","LU0225284248.USD","BK4555","BK4122","LU0225771236.USD","IND","BK4588","NTRB","LU0306806265.USD","BK4007","TM","03160","BK4604","LU0306807586.USD","LU0256331488.USD"],"gpt_icon":0},{"id":"2595377939","title":"Nutriband CEO Publishes Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2595377939","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595377939?lang=en_us&edition=fundamental","pubTime":"2025-12-31 20:00","pubTimestamp":1767182400,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Dec.  31, 2025  (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on ach","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/31/3211738/0/en/Nutriband-CEO-Publishes-Letter-to-Shareholders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","TM","LU2237443549.SGD","LU2746668974.SGD","BK4139","LU2237443978.SGD","NTRBW","IE00BHPRN162.USD","LU0149725797.USD","LU2746668461.USD","BK4555","LU0971096721.USD","LU2237443382.USD","IE00BZ1G4Q59.USD","CMC","LU2237443622.USD","LU2237443895.HKD","LU0170899867.USD","IE00BKVL7J92.USD","CDMO","BK4007","BK4604","03160","NTRB","BK4588","IE00BFXG1179.USD","IND","LU1363072403.SGD","LU0882574139.USD","BK4006","BK4585","LU0267386448.USD","IE00B1BXHZ80.USD","BK4099"],"gpt_icon":0},{"id":"2595733439","title":"Nutriband Inc - Proceeds to Fund Development of Aversa Fentanyl Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2595733439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595733439?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:00","pubTimestamp":1767016800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA5WWNXW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTRBW","BK4007","NTRB"],"gpt_icon":0},{"id":"2595339277","title":"Nutriband Inc - Shareholders to Retain 10% Stake in Earth Vision Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2595339277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595339277?lang=en_us&edition=fundamental","pubTime":"2025-12-29 22:00","pubTimestamp":1767016800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA5WWNXW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NTRBW","NTRB"],"gpt_icon":0},{"id":"2592903585","title":"Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction","url":"https://stock-news.laohu8.com/highlight/detail?id=2592903585","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592903585?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:00","pubTimestamp":1766059200,"startTime":"0","endTime":"0","summary":"Prescription pharmaceutical transdermal fentanyl is a valuable treatment for management of pain in opioid-tolerant patients, severe enough to require daily, around-the-clock, long-term opioid treatmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/18/3207557/0/en/Nutriband-Differentiates-Prescription-Fentanyl-from-Illicit-Fentanyl-in-Response-to-United-States-Executive-Order-Designating-Fentanyl-as-a-Weapon-of-Mass-Destruction.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","NTRB","NTRBW","UBCP","BK4007"],"gpt_icon":0},{"id":"2578953818","title":"Nutriband Inc - Meets With FDA for Aversa Fentanyl Feedback","url":"https://stock-news.laohu8.com/highlight/detail?id=2578953818","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578953818?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:19","pubTimestamp":1761650396,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W913C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTRBW","BK4007","NTRB"],"gpt_icon":0},{"id":"2578959854","title":"Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2578959854","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578959854?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:00","pubTimestamp":1761649200,"startTime":"0","endTime":"0","summary":"Nutriband met with US FDA to obtain feedback on the Chemistry, Manufacturing, and Controls plans for AVERSA FENTANYL (abuse deterrent transdermal system) through commercialization. Nutriband received ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175223/0/en/Nutriband-Announces-Successful-Meeting-Completed-With-United-States-FDA-For-Its-Abuse-Deterrent-Fentanyl-Patch.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0149725797.USD","LU1854103824.USD","LU1720051017.SGD","LU1861219969.SGD","IE00BFXG1179.USD","LU0348723411.USD","CMC","LU2360107325.USD","BK4588","BK4605","LU1861220033.SGD","BK4141","BK4512","LU1548497426.USD","NTRB","LU2237443978.SGD","ON","BK4006","IE00BD6J9T35.USD","LU0882574139.USD","IE00B1BXHZ80.USD","LU2237443382.USD","HAP","BK4585","LU1854104046.USD","LU1978683503.SGD","LU0170899867.USD","LU0124384867.USD","IE00BKVL7J92.USD","LU0724618433.USD","LU2237443895.HKD","LU2298322129.HKD","LU2237443622.USD","LU2357305700.SGD","LU2237443549.SGD","IE00BFMHRM44.USD","IE00BZ1G4Q59.USD","LU0267386448.USD","NTRBW","UBCP","BK4007","IE00BZ199S13.USD","IE00BHPRN162.USD","LU2237443465.HKD","LU1720051108.HKD","LU2746668974.SGD","LU1363072403.SGD","LU2746668461.USD","LU1861215975.USD","LU1861214812.USD"],"gpt_icon":0},{"id":"2578610552","title":"Press Release: Nutriband Co-Founder Gareth Sheridan Returns as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2578610552","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578610552?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:00","pubTimestamp":1761562800,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Oct. 27, 2025  -- Nutriband Inc.  has announced that Company founder, Gareth Sheridan has returned as Company CEO.During the period of August 10 until October 27 , Co-Founder and Chairman, Serguei Melnik had taken over the responsibilities of CEO. Mr Sheridan has returned to the position of CEO effective immediately and will guide the company through the final 2025 framework towards the target NDA filing in 2026 for AVERSA Fentanyl.AVERSA FENTANYL has the potential to be the world's first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl patches. AVERSA FENTANYL has the potential to reach peak annual US sales of $80 million to $200 million. While initially concentrating on the US market, the unmet medical need for adequate pain management is a global problem, and our goal is to make AVERSA FENTANYL available in all major medical markets in the world.Certain statements contained in this p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4588","BK4007","TM","BK4585","BK4099","NTRBW","03160","NTRB","BK4555"],"gpt_icon":0},{"id":"2573923720","title":"Nutriband Inc - Files Provisional Patent Application With Uspto for Aversa Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2573923720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573923720?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:35","pubTimestamp":1759926937,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nFWN3VP1IB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTRB","BK4007","NTRBW"],"gpt_icon":0},{"id":"2573692589","title":"Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2573692589","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573692589?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:30","pubTimestamp":1759926600,"startTime":"0","endTime":"0","summary":"Nutriband files provisional patent application to enhance its AVERSA transdermal abuse deterrent technology being developed for patches containingopioids and stimulants with a potential for abuse. Nut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/08/3163340/0/en/Nutriband-Files-Provisional-Patent-Application-for-Enhanced-Transdermal-Abuse-Deterrent-Technology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTRBW","NTRB","BK4007"],"gpt_icon":0},{"id":"2573942116","title":"Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2573942116","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573942116?lang=en_us&edition=fundamental","pubTime":"2025-10-08 18:30","pubTimestamp":1759919400,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Oct.  08, 2025  (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that its Chairman Serguei Melnik will present at Noble Capital Markets’ Emerging Growt","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/08/3163164/0/en/Nutriband-To-Present-at-the-Noble-Capital-Markets-Emerging-Growth-Virtual-Equity-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4585","NBL","NTRB","BK4215","NTRBW","EQR"],"gpt_icon":0},{"id":"2564319878","title":"Press Release: Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2564319878","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564319878?lang=en_us&edition=fundamental","pubTime":"2025-09-04 04:01","pubTimestamp":1756929660,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Sept. 03, 2025  -- Nutriband Inc. , a company engaged in the development of abuse deterrent pharmaceutical products announced today that it has seen warrants exercised at a strike price of $6.43 for proceeds to the company of $5,306,000.The primary use of proceeds will be used towards the remaining clinical development of AVERSA Fentanyl and submission of its NDA with the FDA for marketing approval. AVERSA Fentanyl has the potential to become the world's first opioid patch with abuse deterrent properties and is estimated it could reach peak annual US sales of $80 million to $200 million.We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.The Com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","NTRBW","TM","BK4604","BK4555","03160","BK4099","BK4585","BK4007","NTRB"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}